CIK: 0001615982 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value ($000): $2,102,200 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 8,493,321 | $564,381 | 26.8% | $22.03 | +98.2% | COM | 03770N101 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,400,000 | $140,184 | 6.7% | $19.48 | +31.0% | COM | 35104E100 |
| OCUL | OCULAR THERAPEUTIX INC | 12,762,462 | $116,138 | 5.5% | $4.57 | +55.1% | COM | 67576A100 |
| SYRE | SPYRE THERAPEUTICS INC | 2,171,782 | $82,376 | 3.9% | $13.78 | +110.3% | COM NEW | 00773J202 |
| — | MERUS N V | 1,790,214 | $80,613 | 3.8% | $20.36 | — | COM | N5749R100 |
| PHVS | PHARVARIS N V | 3,395,606 | $78,472 | 3.7% | $15.96 | +66.4% | COM | N69605108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 6,249,731 | $74,122 | 3.5% | $8.81 | +51.3% | COM | 483497103 |
| ELVN | ENLIVEN THERAPEUTICS INC | 4,026,331 | $70,823 | 3.4% | $18.38 | -16.5% | COM | 29337E102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,882,671 | $67,986 | 3.2% | $19.32 | +0.4% | COM | 92790C104 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,094,373 | $62,831 | 3.0% | $17.70 | +22.8% | COM | 252828108 |
| DYN | DYNE THERAPEUTICS INC | 2,173,913 | $61,717 | 2.9% | $11.80 | +91.7% | COM | 26818M108 |
| — | APPLIED THERAPEUTICS INC | 9,075,000 | $61,710 | 2.9% | $3.13 | — | COM | 03828A101 |
| ORIC | ORIC PHARMACEUTICALS INC | 4,394,527 | $60,425 | 2.9% | $8.55 | +38.9% | COM | 68622P109 |
| — | ASTRIA THERAPEUTICS INC | 3,608,645 | $50,792 | 2.4% | $8.36 | — | COM | 04635X102 |
| — | MERSANA THERAPEUTICS INC | 11,328,000 | $50,749 | 2.4% | $1.27 | — | COM | 59045L106 |
| ENGN | ENGENE HOLDINGS INC | 2,565,841 | $43,491 | 2.1% | $12.24 | 0.0% | COM | 29286M105 |
| PRAX | PRAXIS PRECISION MEDICINES I | 706,126 | $43,088 | 2.0% | $31.41 | +42.8% | COM NEW | 74006W207 |
| — | HILLEVAX INC | 2,075,000 | $34,507 | 1.6% | $13.50 | — | COM | 43157M102 |
| COGT | COGENT BIOSCIENCES INC | 5,129,167 | $34,468 | 1.6% | $8.56 | -27.8% | COM | 19240Q201 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,818,182 | $33,164 | 1.6% | $15.89 | 0.0% | COM | 28036F105 |
| CABA | CABALETTA BIO INC | 1,563,952 | $26,681 | 1.3% | $6.85 | +213.4% | COM | 12674W109 |
| ARVN | ARVINAS INC | 627,788 | $25,915 | 1.2% | $23.38 | +86.9% | COM | 04335A105 |
| TSHA | TAYSHA GENE THERAPIES INC | 9,000,000 | $25,830 | 1.2% | $1.87 | +11.6% | COM SHS | 877619106 |
| AQST | AQUESTIVE THERAPEUTICS INC | 5,555,555 | $23,667 | 1.1% | $3.33 | 0.0% | COM | 03843E104 |
| TERN | TERNS PHARMACEUTICALS INC | 3,410,058 | $22,370 | 1.1% | $4.28 | +52.7% | COM | 880881107 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,556,419 | $22,008 | 1.0% | $14.14 | — | COM NEW | 00773U207 |
| CELC | CELCUITY INC | 970,000 | $20,952 | 1.0% | $10.24 | +56.0% | COM | 15102K100 |
| ABVX | ABIVAX SA | 1,345,780 | $19,245 | 0.9% | $11.63 | — | SPONSORED ADS | 00370M103 |
| IMTX | IMMATICS N.V | 1,750,000 | $18,393 | 0.9% | $11.66 | 0.0% | SHS | N44445109 |
| — | LYRA THERAPEUTICS INC | 2,576,093 | $16,023 | 0.8% | $5.39 | — | COM | 55234L105 |
| CGON | CG ONCOLOGY INC | 350,000 | $15,365 | 0.7% | $40.84 | 0.0% | COM | 156944100 |
| IPSC | CENTURY THERAPEUTICS INC | 3,405,133 | $14,233 | 0.7% | $4.23 | 0.0% | COM | 15673T100 |
| TRVI | TREVI THERAPEUTICS INC | 3,422,675 | $11,808 | 0.6% | $2.46 | -9.4% | COM | 89532M101 |
| TNYA | TENAYA THERAPEUTICS INC | 1,555,556 | $8,136 | 0.4% | $4.78 | 0.0% | COM | 87990A106 |
| MLYS | MINERALYS THERAPEUTICS INC | 555,554 | $7,172 | 0.3% | $12.35 | 0.0% | COM | 603170101 |
| — | ACELYRIN INC | 937,113 | $6,326 | 0.3% | $9.96 | — | COM | 00445A100 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 250,000 | $5,168 | 0.2% | $11.18 | +121.5% | COM NEW | 30233G209 |
| OLMA | OLEMA PHARMACEUTICALS INC | 77,042 | $872 | 0.0% | $10.19 | +26.6% | COM | 68062P106 |